Splanchnic vein thrombosis mainly includes portal vein thrombosis, mesenteric vein thrombosis, and Budd-Chiari syndrome, which often result in lethal complications. Recent advances in the diagnosis and treatment of splanchnic vein thrombosis have greatly improved the prognosis of the patients. However, the current recommendations for the treatment strategy are still based on the expert opinions and results of low-quality studies.

We invite the researchers to contribute original research articles and review articles to explore the etiology, diagnosis, and treatment of portal vein thrombosis, mesenteric vein thrombosis, and Budd-Chiari syndrome. We are particularly interested in high-quality systematic reviews and meta-analyses in this field.

Potential topics include, but are not limited to:

• Epidemiology and clinical significance of portal vein thrombosis in liver cirrhosis
• Management of portal vein thrombosis after abdominal and pelvic surgery
• Pathogenesis of splanchnic vein thrombosis, especially myeloproliferative neoplasms and inherited thrombophilia
• Imaging diagnosis of splanchnic vein thrombosis
• Treatment of splanchnic vein thrombosis, especially anticoagulation therapy, thrombolysis, transjugular intrahepatic portosystemic shunt, Rex shunt, and liver transplantation